Omata 1991.
| Methods | Randomisation: yes Blinding: no Intention to treat: yes Methodological score: 12 | |
| Participants | ‐ Patients with acute hepatitis C ‐ n = 25 ‐ Arms (IFN/C): 11/14 ‐ RNA + at entry: 10/12 ‐ Excluded: 0/0 ‐ Mean age (y): 40/38 ‐ Male (%): 44/50 ‐ Transfusion (%): 88/71 ‐ Drug abuse (%): NDA ‐ Genotype: NDA ‐ Mean disease duration: NDA | |
| Interventions | ‐ Schedule: Control: no intervention Experimental: IFN beta 3 MU/d x 5 days; 3 MU tiw x 3 wk ‐ F/U: 12 mo | |
| Outcomes | ‐ Biochemical ETR ‐ Virologic ETR | |
| Notes | ||
| Risk of bias | ||
| Bias | Authors' judgement | Support for judgement |
| Allocation concealment? | Unclear risk | B ‐ Unclear |